These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
416 related items for PubMed ID: 2724998
1. Surgical decisions in the management of sudden cardiac death and malignant ventricular arrhythmias. Subendocardial resection, the automatic internal defibrillator, or both. Hargrove WC, Josephson ME, Marchlinski FE, Miller JM. J Thorac Cardiovasc Surg; 1989 Jun; 97(6):923-8. PubMed ID: 2724998 [Abstract] [Full Text] [Related]
2. Risk stratification and management of patients with recurrent ventricular tachycardia and other malignant ventricular arrhythmias. Hargrove WC, Miller JM. Circulation; 1989 Jun; 79(6 Pt 2):I178-81. PubMed ID: 2720941 [Abstract] [Full Text] [Related]
3. Treatment of malignant ventricular arrhythmias with endocardial resection and implantation of the automatic cardioverter-defibrillator. Platia EV, Griffith LS, Watkins L, Mower MM, Guarnieri T, Mirowski M, Reid PR. N Engl J Med; 1986 Jan 23; 314(4):213-6. PubMed ID: 3941709 [Abstract] [Full Text] [Related]
4. [Long-term outcome of pharmacological and nonpharmacological treatment for ventricular arrhythmias]. Ohnishi S, Kasanuki H. J Cardiol; 2000 Mar 23; 35 Suppl 1():75-84. PubMed ID: 10834174 [Abstract] [Full Text] [Related]
8. Results of electrophysiologically guided operations for drug-resistant recurrent ventricular tachycardia and ventricular fibrillation due to coronary artery disease. Brodman R, Fisher JD, Johnston DR, Kim SG, Matos JA, Waspe LE, Scavin GM, Furman S. J Thorac Cardiovasc Surg; 1984 Mar 23; 87(3):431-8. PubMed ID: 6700249 [Abstract] [Full Text] [Related]
9. The automatic implantable cardioverter defibrillator as a therapeutic modality for recurrent ventricular tachycardia: a case study. Kuiper RA. Prog Cardiovasc Nurs; 1990 Mar 23; 5(1):6-12. PubMed ID: 2367517 [Abstract] [Full Text] [Related]
11. Long-term incidence of malignant ventricular arrhythmia and shock therapy in patients with primary defibrillator implantation does not differ from event rates in patients treated for survived cardiac arrest. Backenköhler U, Erdogan A, Steen-Mueller MK, Kuhlmann C, Most A, Schaefer C, Stertmann W, Waas W, Tillmanns H, Waldecker B. J Cardiovasc Electrophysiol; 2005 May 23; 16(5):478-82. PubMed ID: 15877617 [Abstract] [Full Text] [Related]
12. A Canadian hospital's experience with the automatic implantable cardioverter/defibrillator. Sharma AD, Guiraudon G, Klein GJ, Yee R. CMAJ; 1987 Nov 01; 137(9):809-15. PubMed ID: 3442769 [Abstract] [Full Text] [Related]
13. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. Active Can Investigators. Bardy GH, Yee R, Jung W. J Am Coll Cardiol; 1996 Aug 01; 28(2):400-10. PubMed ID: 8800117 [Abstract] [Full Text] [Related]
15. Automatic implantable defibrillator for the patient with recurrent refractory malignant ventricular arrhythmias: case report. Stack JM, Houston C, Mirowski M, Mower M, Watkins L, Reid PR. Heart Lung; 1982 Aug 01; 11(6):512-5. PubMed ID: 6922850 [Abstract] [Full Text] [Related]
17. [Implantable defibrillators]. Klein H, Trappe HJ. Z Gesamte Inn Med; 1992 May 01; 47(5):209-17. PubMed ID: 1615731 [Abstract] [Full Text] [Related]
18. Operative risks of the implantable defibrillator versus endocardial resection. Kron IL, Haines DE, Tribble CG, Blackbourne LH, Flanagan TL, Hobson CE, DiMarco JP. Ann Surg; 1990 May 01; 211(5):600-3; discussion 603-4. PubMed ID: 2339921 [Abstract] [Full Text] [Related]